Medical Devices
CONTAK RENEWAL and CONTAK RENEWAL 2 CRT-Ds
Class 1 Recall
|
Date Recall Initiated:
|
June 29, 2005 |
|---|---|
|
Product:
|
CONTAK RENEWAL Model H135 Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) manufactured on or before August 26, 2004; and CONTAK RENEWAL 2 Model H155 Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) manufactured on or before August 26, 2004. |
|
Use:
|
These devices are surgically implanted in persons who have a type of heart disease that creates the risk of a life-threatening heart arrhythmia (abnormal rhythm). The devices deliver an electrical shock to the heart to restore normal heart rhythm. |
|
Recalling Firm:
|
Guidant Corporation |
|
Reason for Recall:
|
A deterioration in a wire insulator could cause a short circuit, resulting in the device’s inability to deliver an electrical shock during episodes of arrhythmia (abnormal heart rhythm) -- which could lead to a serious, life-threatening event for a patient. |
|
Public Contact:
|
Consumers with questions may contact Guidant Corporation at 1-866-GUIDANT (1-866-484-3268) |
|
FDA District:
|
Minneapolis |
|
FDA Comment:
|
Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the product will cause serious injury or death. |
| For additional information on this product recall, see the nearby links. |
Useful Links
FDA Issues Nationwide Notification of Recall of Certain Guidant Implantable Defibrillators and Cardiac Resynchronization Therapy Defibrillators [ARCHIVED]FDA Preliminary Public Health Notification*: Guidant VENTAK PRIZM® 2 DR and CONTAK RENEWAL® Implantable Cardioverter Defibrillators [ARCHIVED]Advice for Patients with VENTAK PRIZM® 2 DR and CONTAK RENEWAL® Implantable Cardioverter Defibrillators [ARCHIVED]







